Dec
2026
Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia
Visit us
stand H1.V110

AMN Life Science PVT Ltd

Exhibitor at CPHI Middle East 2026
About Us

AMN LIFE headquartered in Mumbai at The Capital, BKC since 2003 engaged in activities of pharmaceuticals product development, manufacturing and marketing.We are vertically integrated by having its own 2 manufacturing units of finished dosage forms to cater general OSD & beta lactum products having multiple regulated accreditations from various authorities across the globe including EU / Canada etc. AMN offers end to end solutions including CDMO, CMO, In licensing, Out licensing, Tech transfer, dossier rectification etc.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    India
  • On CPHI since:
    2017
  • Certificates:
    2
  • Employees:
    500 - 999
Company types
Manufacturer/Innovator
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Middle East 2026
  • 14 Dec 2026 - 16 Dec 2026
  • Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia
  • Visit us at stand H1.V110

Products Featured at CPHI Middle East 2026

  • Beta Drugs Ltd.

    Product Beta Drugs Ltd.

    Sl No.Product Name 1Abiraterone Tablets 250 mg 2Anastrozole tablets 1 mg 3Bendamustin Injection 100 mg/ vial 4Bicalutamide Tablets 50 mg 5Bortezomib Injection 2 mg/ vial 6Capecitabine Tablets 500 mg 7Carboplatin Inejction 10 mg/ 1 ml, 150mg 8Carboplatin Inejction 10 mg/ 1 ml, 450mg 9Cisplatin 10 mg/ 20 ml,...
  • Finished Dosage formulations

    Product Finished Dosage formulations

    A comprehensive portfolio of innovative finished formulations including ODTs, sustained-release capsules, and taste-masked syrups—designed to enhance patient adherence, improve bioavailability, and ensure stability across diverse climates. Backed by in-house R&D and API manufacturing, our products are ...
  • Finished Dosage formulations

    Product Finished Dosage formulations

    A comprehensive portfolio of innovative finished formulations including ODTs, sustained-release capsules, and taste-masked syrups designed to enhance patient adherence, improve bioavailability, and ensure stability across diverse climates. Backed by in-house R&D and API manufacturing, our products are ...